Other Names for this Disease
- Familial recurrent peripheral facial palsy
- Inflammation of the whole uveal tract
- Total uveitis
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
uvea of the eye, which includes the iris, ciliary body, and choroid. These make up the middle layer of the eye. The condition can also affect the lens, retina, optic nerve, and vitreous, causing reduced vision or blindness. Signs and symptoms may include eye redness and pain; blurring; light sensitivity; decreased vision; and seeing floaters. It can last for a short time or can occur chronically. Severe cases may recur many times. In many cases the specific cause is unknown, but in some cases it occurs in association with other eye conditions, or with another condition or infection that also affects other body parts. Early treatment is needed and may include eye drops to reduce inflammation and pain, and/or oral medications or injections in severe cases.Panuveitis is inflammation of all layers of the
Last updated: 7/22/2014
- Kierstan Boyd. What is uveitis?. American Academy of Ophthalmology. March 1, 2014; http://www.geteyesmart.org/eyesmart/diseases/uveitis/index.cfm. Accessed 7/22/2014.
- Facts About Uveitis. National Eye Institute. August, 2011; http://www.nei.nih.gov/health/uveitis/uveitis.asp. Accessed 7/22/2014.
- The American Academy of Ophthalmology Web site has an information page on Panuveitis. Their Web site is dedicated to educating people about eye diseases and conditions and the preservation of eye health.
- MedlinePlus was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.
- The Merck Manual provides information on this condition for patients and caregivers.
- The National Eye Institute (NEI) was established by Congress in 1968 to protect and prolong the vision of the American people. Click on the link to view information on this topic.